Erica Jackson

Erica Jackson is currently the Chief Discovery Officer and Executive Vice President, Target Biology at Scorpion Therapeutics. Prior to this, Erica held positions such as Senior Director at AbbVie, Head of Biology at Pharmacyclics, Director of Biology at ORIC Pharmaceuticals, and various roles at Genentech. Erica completed their PhD in Biology at the Massachusetts Institute of Technology after obtaining their BA in Biology from Brandeis University.